Loading…
Loading…
M7U.DE does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for M7U.DE and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for M7U.DE and 80,000+ other tickers.
See exactly how M7U.DE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for M7U.DE and 80,000+ other tickers.
Based in Wedel, Germany, Nynomic AG, founded in 1995, operates as a global developer and producer of advanced technological solutions. The company provides a comprehensive range of products spanning spectroscopy, sensor technology, laboratory automation, and applications for medical, agricultural, environmental, and industrial markets. Its diverse portfolio encompasses sophisticated photonic solutions, specialized OEM components, and embedded systems. Nynomic offers various precision measurement tools, including UV-VIS-NIR and Raman spectrometer systems, miniature fiber-optic spectrometers…
No recent news available.